These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23757262)

  • 1. Affective disorders in Parkinson's disease.
    Aminian KS; Strafella AP
    Curr Opin Neurol; 2013 Aug; 26(4):339-44. PubMed ID: 23757262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging correlates of apathy and depression in Parkinson's disease.
    Benoit M; Robert PH
    J Neurol Sci; 2011 Nov; 310(1-2):58-60. PubMed ID: 21831400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood Disorders and Anxiety in Parkinson's Disease: Current Concepts.
    Lintel H; Corpuz T; Paracha SU; Grossberg GT
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):280-288. PubMed ID: 34219518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI of Motor and Nonmotor Therapy-Induced Complications in Parkinson's Disease.
    Donzuso G; Agosta F; Canu E; Filippi M
    Mov Disord; 2020 May; 35(5):724-740. PubMed ID: 32181946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmotor symptoms in Parkinson's disease.
    Stacy M
    Int J Neurosci; 2011; 121 Suppl 2():9-17. PubMed ID: 22035025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Motor, cognitive and affective disorders in Parkinson's disease].
    Vendrova MI; Golubev VL; Sadekov RA; Veĭn AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(3):13-7. PubMed ID: 12830500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of emotional prosody in Parkinson's disease.
    Schröder C; Nikolova ZT; Dengler R
    J Neurol Sci; 2010 Feb; 289(1-2):32-5. PubMed ID: 19732910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?
    Loued-Khenissi L; Preuschoff K
    Curr Opin Neurol; 2015 Aug; 28(4):344-50. PubMed ID: 26110801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premotor symptoms and early diagnosis of Parkinson's disease.
    Adler CH
    Int J Neurosci; 2011; 121 Suppl 2():3-8. PubMed ID: 22035024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of mood and anxiety fluctuations in Parkinson's disease patients with motor fluctuations: A systematic review.
    van der Velden RMJ; Broen MPG; Kuijf ML; Leentjens AFG
    Mov Disord; 2018 Oct; 33(10):1521-1527. PubMed ID: 30225905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies in Parkinson's disease.
    Jankovic J; Poewe W
    Curr Opin Neurol; 2012 Aug; 25(4):433-47. PubMed ID: 22691758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
    Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
    Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The habenula in Parkinson's disease: Anatomy, function, and implications for mood disorders - A narrative review.
    Samanci B; Tan S; Michielse S; Kuijf ML; Temel Y
    J Chem Neuroanat; 2024 Mar; 136():102392. PubMed ID: 38237746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders affecting the emotional sphere and impulse control in Parkinson's disease].
    Fernández-Prieto M; Lens M; López-Real A; Puy A; Dias-Silva JJ; Sobrido MJ
    Rev Neurol; 2010 Feb; 50 Suppl 2():S41-9. PubMed ID: 20205141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.
    Christopher L; Koshimori Y; Lang AE; Criaud M; Strafella AP
    Brain; 2014 Aug; 137(Pt 8):2143-54. PubMed ID: 24736308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of transcranial magnetic stimulation in treatment of affective disorders in Parkinson's disease].
    Kashezhev AG; Sinkin MV; Skripkina NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):66-69. PubMed ID: 28980615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-wake disturbances in the premotor and early stage of Parkinson's disease.
    Bargiotas P; Schuepbach MW; Bassetti CL
    Curr Opin Neurol; 2016 Dec; 29(6):763-772. PubMed ID: 27798423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.